Synthes, Inc. recalls TFN-ADVANCED Proximal Femoral Nailing System (TFNA); for treatment of fractures in orthopedics and trauma.

Recalled May 20, 2015 · FDA recall Z-1600-2015 · Synthes

Hazard

TFNA nails from certain lots were assembled with a locking mechanism too close to the top of the nail. Potential patient impact: surgical delay. · FDA Class II

Units

8175

Sold at

Distribution US Nationwide and Switzerland.

Description

TFNA nails from certain lots were assembled with a locking mechanism too close to the top of the nail. Potential patient impact: surgical delay.

Product

TFN-ADVANCED Proximal Femoral Nailing System (TFNA); for treatment of fractures in orthopedics and trauma.

Manufacturer(s)

Synthes, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →